Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Roche and Protein Design Labs report encouraging results from Zenapax trial

May 20, 1997

Phase I/II results for promising compound from BioTransplant and MedImmune

May 20, 1997

BioChem Pharma subsidiary signs agreement to develop nasally delivered vaccines

May 14, 1997

Fujisawa's Prograf cleared by FDA for use in kidney transplantation

May 9, 1997

Nippon Shinyaku prepares improved ciclosporin derivatives

May 9, 1997

Aquila's QS-21 enhances immune response of DNA vaccines in preclinical studies

May 9, 1997

Alexion issued two patents covering technology for xenotransplantation products

May 9, 1997

Zeneca and University of California to codevelop drugs for immunosuppression

May 8, 1997

Novel semisynthetic macrolide immunosuppressants disclosed by Abbott

May 7, 1997

Potential HSV-2 vaccine described by Aviron

May 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...